Radiation therapy for head and neck skin cancer study
Part of Cancer clinical trials.
This study looks at the role of radiation therapy in treating non-melanoma skin cancers (like basal cell carcinoma or squamous cell carcinoma) on the head and neck. It may help doctors better understand how well this treatment works and who benefits most.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You were treated with radiation therapy as your first or main treatment for a type of skin cancer called basal cell carcinoma or cutaneous squamous cell carcinoma.
- Your cancer was on your head or neck.
- You received this treatment between 2020 and 2024.
- You can communicate in either Danish or English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a focused radiation treatment after surgery for people with a common skin cancer (squamous cell carcinoma) that has spread to the lymph nodes in the neck or near the ear. The goal is to see if this approach can prevent the cancer from coming back.
This trial studies a combination of Mohs surgery and a short course of radiation therapy for people with squamous cell skin cancer of the head and neck. The goal is to see if this approach is effective with fewer side effects.
This study looks at whether radiation therapy after surgery helps people with a high-grade type of skin cancer called squamous cell carcinoma. It may help doctors understand who benefits most from this additional treatment.
This trial compares two strategies after surgery for a type of skin cancer (cutaneous squamous cell carcinoma) that has a high chance of coming back. One strategy gives radiation therapy to the area, while the other just watches and checks for any signs of recurrence. The goal is to see if radiation can prevent the cancer from returning.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
This study tests whether adding immunotherapy drugs (nimotuzumab and possibly benmelstobart) to radiation therapy after head and neck cancer surgery improves outcomes. You may qualify if you've recently had surgery for squamous cell carcinoma (a common type of head and neck cancer) and have certain risk factors that suggest your cancer could return.
Hear when a new Basal Cell Carcinoma of Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.